<- Go Home
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$134.5B
Volume
6.3M
Cash and Equivalents
$2.5B
EBITDA
$4.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$10.9B
Profit Margin
68.74%
52 Week High
$91.93
52 Week Low
$57.77
Dividend
N/A
Price / Book Value
6.50
Price / Earnings
75.51
Price / Tangible Book Value
-1.6K
Enterprise Value
$143.5B
Enterprise Value / EBITDA
34.48
Operating Income
$2.8B
Return on Equity
8.92%
Return on Assets
4.90
Cash and Short Term Investments
$2.5B
Debt
$11.3B
Equity
$21.0B
Revenue
$15.9B
Unlevered FCF
$2.0B
Sector
Health Care Equipment and Supplies
Category
N/A
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick Premium